ZLDAF
Zelira Therapeutics Limited

29
Mkt Cap
$3.93M
Volume
1,005.00
52W High
$0.5078
52W Low
$0.2116
PE Ratio
-1.08
ZLDAF Fundamentals
Price
$0.2223
Prev Close
$0.2426
Open
$0.2223
50D MA
$0.2416
Beta
0.13
Avg. Volume
31.48
EPS (Annual)
-$0.2046
P/B
-0.90
Loading...
Loading...
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Zelira Therapeutics Limited?
What is the 52-week high for Zelira Therapeutics Limited?
What is the 52-week low for Zelira Therapeutics Limited?
What is Zelira Therapeutics Limited stock price today?
What was Zelira Therapeutics Limited stock price yesterday?
What is the PE ratio of Zelira Therapeutics Limited?
What is the Price-to-Book ratio of Zelira Therapeutics Limited?
What is the 50-day moving average of Zelira Therapeutics Limited?

Latest ZLDAF News

View
No ZLDAF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.